Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression

Environmental Health Perspectives

Volumn 112, Issue 4, 2004, Pages 423-427

  Ulrich, Roger G ^a   Rockett, John C ^b   Gibson, G Gordon ^c   Pettit, Syril D ^d  

^a ROSETTA INPHARMATICS   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d International Life Sciences Institute   (United States)

Author keywords

Clofibrate; Gene expression profiling; Liver; Methapyrilene; Microarrays; qRT PCR; Rat; Toxicogenomics

Indexed keywords

ACYL COENZYME A OXIDASE; CLOFIBRATE; METHAPYRILENE;

DNA MICROARRAY; ENVIRONMENTAL HEALTH; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; IN VIVO STUDY; LIVER TOXICITY; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RELIABILITY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT;

EID: 1542361727     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.6675     Document Type: Review

References (29)

1. Amacher DE, Beck R, Schomaler SJ, Kenny CV. 1997. Hepatic microsomal enzyme induction, β-oxidation and cell proliferation following administration of clofibrate, gemfibrozil or bezafibrate in the CD rat. Toxicol Appl Pharmacol 142:143-150.
2. Baker VA, Harries HM, Waring JF, Duggan CM, Ni HA, Jolly RA et al. 2004. Clofibrate-induced gene expression changes in rat liver: A cross-laboratory analysis using membrane cDNA arrays. Environ Health Perspect 112:428-438.
3. Burczynski ME, McMillian M, Ciervo J, Li L, Parker JB, Dunn RT II, et al. 2000. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol Sci 58:399-415.
4. CDER-PhRMA-AASLD Conference 2000. Clinical White Paper. Available: Http://www.fda.gov/cder/livertox [accessed 9 January 2004].
5. Chu T-M, Deng S, Wolfinger IR, Paules RS, Hamadeh HK. 2004. Cross-site comparison of gene expression data reveals high similarity. Environ Health Perspect 112:449-455.
6. Corton JC, Anderson SP, Stauber A. 2000. Central role of peroxisome proliferators-activated receptors in the actions of peroxisome proliferators. Ann Rev Pharmacol Toxicol 40:491-518.
7. Gerhold D, Lu M, Xu J, Austin C, Caskey C, Rushmore T. 2001. Monitoring expression of genes involved in drug metabolism using DNA microarrays. Physiol Genomics 5:161-170.
8. Goodsaid FM, Smith RJ, Zairov H and Rosenblum IY. 2004. Quantitative PCR deconstruction of discrepancies between results reported by different hybridization platforms. Environ Health Perspect 112:456-459.
9. Graichen ME, Neptun DA, Dent JG, Popp JA, Leonard TB. 1985. Effects of methapyrilene on rat hepatic xenobiotic metabolizing enzymes and liver morphology. Fundam Appl Toxicol 5:165-174.
10. Hamadeh HK, Bushel PR, Jayadev S, Martin K, DiSorbo O, Sieber S, et al. 2002a. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 67:219-231.
11. Hamadeh HK, Knight BL, Haugen AC, Sieber S, Amin RP, Bushel et al. 2002b. Methapyrilene toxicity: Anchorage of pathologic observations to gene expression alterations. Toxicol Pathol 30:470-482.
12. Green S. 1995. PPAR: A mediator of peroxisome proliferator action. Mutat Res 333:101-109.
13. Karbowski J, Kochan Z, Zelewski L, Swierczynski J. 1999. Tissue-specific effect of clofibrate on rat lipogenic enzyme gene expression. Eur J Pharmacol 370:329-336.
14. Kier L, Nolan T. 2003. Gene expression biomarkers that accurately predict kidney tubular necrosis [Abstract]. Toxicol Sci 72:151.
15. Latruffe N, Cherkaoui, MM, Nicolas-Frances V, Jannin B, Clements MC, Hansmannel F, et al. 2001. Peroxisome-proliferator-activated receptors as physiological sensors of fatty acid metabolism: Molecular regulation in peroxisomes. Biochem Soc Trans 29:305-309.
16. Mirsalis JC. 1987. Genotoxicity, toxicity, and carcinogenicity of the antihistamine methapyrilene. Mutat Res 185(3):309-317.
17. Mitchell JR, Snodgrass WR, Gillette JR. 1976. The role of biotransformation in chemical-induced liver injury. Environ Health Perspect 15:27-38.
18. National Center for Toxicogenomics. 2000. Available: http://iccvam.niehs.nih.gov/methods/invidocs/NCTPaper.pdf [accessed 8 July 2003].
19. Noguchi S, Inukai T, Kuno T, Tanaka C. 1992. The suppression of olfactory bulbectomy-induced muricide by antidepressants and antihistamines via histamine H1 receptor blocking. Physiol Behav 51:1123-1127.
20. Pennie WD, Pettit SD, Lord PG. 2004. Toxicogenomics in risk assessment: An overview of an HESI collaborative research program. Environ Health Perspect 112:417-419.
21. Reddy JK, Goel SK, Nemali MR, Carrino JJ, Laffler TG, Reddy MK, et al. 1986. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc Natl Acad Sci USA 83:1747-1751.
22. Reddy JK, Qureshi SA. 1979. Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in rats. Br J Cancer 140:476-482.
23. Steinmetz KL, Tyson CK, Meierhenry EF, Spalding JW, Mirsalis JC, 1988. Examination of genotoxicity, toxicity and morphologic alterations in hepatocytes following in vivo or in vitro exposure to methapyrilene. Carcinogenesis 9:959-963.
24. Thomas RS, Rank DR, Penn SG, Zastrow GM, Hayes KR, Pande K, et al. 2001. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol 60:1189-1194.
25. von Daniken A, Lutz WK, Schlatter C. 1981. Lack of covalent binding to rat liver DNA of the hypolipidemic drugs clofibrate and fenofibrate. Toxicol Lett 7:305-310.
26. Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG. 2001a. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett 120:359-368.
27. Waring JF, Jolly RA, Ciurlionis R, Lum PY, Praestgaard JT, Morfitt DC, et al. 2001b. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol 175:28-42.
28. Waring JF, Ulrich RG, Flint N, Morfitt D, Kalkul A, Staedtler F, et al. 2004. Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene. Environ Health Perspect 112:439-448.
29. Zimmerman HJ. 1976. Various forms of chemically induced liver injury and their detection by diagnostic procedures. Environ Health Perspect 15:3-12.